Tharimmune, Inc. (THAR)

2.54 +0.09 (+3.67%) USD  |  NASDAQ  |  Dec 24, 12:59
2.54 0.00 (0.00%) After-Hours: 13:59
More

Tharimmune SG&A Expense (TTM): 6.835M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for THAR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Phio Pharmaceuticals Corp. 4.234M
ETHZilla Corp. 229.01M
Flora Growth Corp. 2.383M
NovaBay Pharmaceuticals, Inc. 8.584M
Palatin Technologies, Inc. 7.449M